Merck & Co., Inc. (MRK)
147.74
-0.60
(-0.41%)
USD |
NYSE |
Aug 31, 16:00
148.32
+0.58
(+0.39%)
After-Hours: 20:00
Merck Cash from Operations (Annual) : 16.47B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 16.47B |
| December 31, 2024 | 21.47B |
| December 31, 2023 | 13.01B |
| December 31, 2022 | 19.10B |
| December 31, 2021 | 14.11B |
| December 31, 2020 | 10.25B |
| December 31, 2019 | 13.44B |
| December 31, 2018 | 10.92B |
| December 31, 2017 | 6.451B |
| December 31, 2016 | 10.38B |
| December 31, 2015 | 12.54B |
| December 31, 2014 | 7.86B |
| December 31, 2013 | 11.65B |
| December 31, 2012 | 10.02B |
| December 31, 2011 | 12.38B |
| December 31, 2010 | 11.47B |
| December 31, 2009 | 3.392B |
| December 31, 2008 | 8.471B |
| December 31, 2007 | 6.999B |
| December 31, 2006 | 6.765B |
| December 31, 2005 | 7.608B |
| December 31, 2004 | 8.799B |
| Date | Value |
|---|---|
| December 31, 2003 | 8.426B |
| December 31, 2002 | 9.529B |
| December 31, 2001 | 9.080B |
| December 31, 2000 | 7.687B |
| December 31, 1999 | 6.131B |
| December 31, 1998 | 5.328B |
| December 31, 1997 | 6.317B |
| December 31, 1996 | 5.428B |
| December 31, 1995 | 2.944B |
| December 31, 1994 | 4.140B |
| December 31, 1993 | 3.048B |
| December 31, 1992 | 2.504B |
| December 31, 1991 | 2.434B |
| December 31, 1990 | 2.056B |
| December 31, 1989 | 1.381B |
| December 31, 1988 | 1.387B |
| December 31, 1987 | 1.323B |
| December 31, 1986 | 1.094B |
| December 31, 1985 | 1.009B |
| December 31, 1984 | 740.94M |
| December 31, 1983 | 747.04M |
| December 31, 1982 | 625.80M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Pfizer Inc. | 11.70B |
| Bristol Myers Squibb Co. | 14.16B |
| Abbott Laboratories | 9.566B |